Skip to content
zameds

Letrozole

Sold as Femara, Accord-letrozole, Laradex, Letoz, Letrozole adco, Femzole, Rozara, Zetra, Medpro letrozole, Cipla letrozole, Letraz, Rozilat, Fazalet, Lerotizar

S4Read from the PI-PIL document and verified
Loading the molecular structure
C17H11N5285.30 g/mol

4-[(4-Cyanophenyl)-(1,2,4-triazol-1-yl)methyl]benzonitrile

Drag to rotate. Structure from PubChem CID 3902.

Background

Loading...
Loading Wikipedia summary

Registration

Applicants
10
Registrations
14
Schedule source
SAHPRA documentation

Applicants and registrations

ApplicantBrandsDosagesRegistrationsScheduleLeaflets
Novartis South Africa (Pty) LtdFemara2,5310378S4PIPIL
Accord Healthcare (Pty) LtdAccord-letrozole2,5 mg420323S4None
Eurolab (Pty) LtdLaradexNot stated420324S4None
Zydus Healthcare (Pty) LtdLetoz2,5430726S4None
Adcock Ingram Critical Care (Pty) Ltd1 of 2 cancelledLetrozole adco, Femzole2,5430733, 430734S4None
Ascendis Pharma (Pty) LtdRozaraNot stated440154S4None
Pharmaplan (Pty) LtdCancelledZetraNot stated440190S4None
Cipla Medpro (Pty) Ltd1 of 2 cancelledMedpro letrozole, Cipla letrozole2,5440281, 440282S4None
Equity Pharmaceutical (Pty) LtdCertificate held by Equity Pharmaceuticals (Pty) LtdLetraz2.5 mg450544S4PIPIL
Aurogen South Africa (Pty) LtdCertificate held by Aurogen SA (Pty) LtdRozilat, Fazalet, Lerotizar2.5 mg550204, 550205.204, 550206.204S4PIPIL

Variants

ProductStrength and formRegistrationStatusScheduleLeaflets
Femara 2,5

EACH TABLET CONTAINS LETROZOLE 2,5 mg

2,5Film-coated tablets31037831/21.12/0378Approved 5 August 2025RegisteredS4PIPIL
Accord-letrozole 2,5 MG

EACH TABLET CONTAINS LETROZOLE 2,5 mg

2,5 mg42032342/21.12/0323RegisteredS4None
Laradex

EACH TABLET CONTAINS LETROZOLE 2,5 mg

Not listed42032442/21.12/0324RegisteredS4None
Letoz 2,5 tablets

EACH TABLET CONTAINS LETROZOLE 2,5 mg

2,5Tablets43072643/21.12/0726RegisteredS4None
Letrozole adco 2,5

EACH TABLET CONTAINS LETROZOLE 2,5 mg

2,543073343/21.12/0733CancelledS4None
Femzole 2,5

EACH TABLET CONTAINS LETROZOLE 2,5 mg

2,543073443/21.12/0734RegisteredS4None
Rozara

EACH TABLET CONTAINS LETROZOLE 2,5 mg

Not listed44015444/21.12/0154RegisteredS4None
Zetra

EACH TABLET CONTAINS LETROZOLE 2,5 mg

Not listed44019044/21.12/0190CancelledS4None
Medpro letrozole 2,5

EACH TABLET CONTAINS LETROZOLE 2,5 mg

2,544028144/21.12/0281CancelledS4None
Cipla letrozole 2,5

EACH TABLET CONTAINS LETROZOLE 2,5 mg

2,544028244/21.12/0282RegisteredS4None
Letraz

EACH TABLET CONTAINS LETROZOLE 2,5 mg

2.5 mgFilm-coated tablet.45054445/21.12/0544Approved 6 May 2022RegisteredS4PIPIL
Rozilat

EACH TABLET CONTAINS LETROZOLE 2,5 mg

2.5 mgTablets55020455/21.12/0204Approved 29 June 2021RegisteredS4PIPIL
Fazalet

EACH TABLET CONTAINS LETROZOLE 2,5 mg

2.5 mgTablets550205.20455/21.12/0205.204Approved 29 June 2021RegisteredS4PIPIL
Lerotizar

EACH TABLET CONTAINS LETROZOLE 2,5 mg

2.5 mgTablets550206.20455/21.12/0206.204Approved 29 June 2021RegisteredS4PIPIL

Regulatory status

Where S4 sits on the scale

Prescription-only medicine.

Schedule 4 covers most ordinary prescription medicines. You need a prescription from an authorised prescriber, such as a doctor or dentist, and a pharmacist dispenses it. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.

Schedule S4, read from the product's PI-PIL leaflet.

Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it; and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.

Consolidated Schedules listings for Letrozole

  • S4: Letrozole

    Consolidated Schedules 06 July 2026, line 6898

Pharmacological class: Hormone inhibitors. (class 21.12)

This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.

SAHPRA documents

Schedule verified from official documents

Schedule Verification

Femara 2,5, Novartis South Africa (Pty) Ltd is scheduled S4 in its official SAHPRA documents, read with 90% confidence.

Professional information (PI)For healthcare professionalsFemara 2,5, Novartis South Africa (Pty) LtdPatient information leaflet (PIL)For patients and carersFemara 2,5, Novartis South Africa (Pty) Ltd

These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.

Research articles

Loading...
Loading PubMed articles